The Kiss‑1/Kiss‑1R complex as a negative regulator of cell motility and cancer metastasis (Review)

Ji,Ke; Ye,Lin; Mason,Malcolm  D.; Jiang,Wen  G.

doi:10.3892/ijmm.2013.1472

The Kiss‑1/Kiss‑1R complex as a negative regulator of cell motility and cancer metastasis (Review)

Authors:
- Ke Ji
- Lin Ye
- Malcolm D. Mason
- Wen G. Jiang
View Affiliations

Affiliations: Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff, Wales CF14 4XN, UK
Published online on: August 21, 2013 https://doi.org/10.3892/ijmm.2013.1472
Pages: 747-754

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metastasis is a complex multistep process that involves the impairment of cell-cell adhesion in the neoplastic epithelium, invasion into adjacent tissues and the dissemination of cancer cells through the lymphatic and haematogenous routes. The inhibition of the metastatic process at an early stage has become a hot topic in cancer research. The Kiss‑1 gene, initially described as a suppressor of metastasis in malignant melanoma, encodes the Kiss‑1 protein which can be processed to other peptides, e.g., Kisspeptin‑10, Kisspeptin‑13, Kisspeptin‑14 and Kisspeptin‑54. These peptides are endogenous ligands of the Kiss‑1 receptor (Kiss‑1R), a G protein‑coupled receptor (GPR) also known as hOT7T175, AXOR12 or GPR54. The Kiss‑1 gene has been suggested as a suppressor of metastasis in a various types of cancer, including gastric cancer, oesophageal carcinoma, pancreatic, ovarian, bladder and prostate cancer, through the regulation of cellular migration and invasion. In the current review, we summarise the current understanding of the role of Kiss‑1 and Kiss‑1R in cancer and cancer metastasis.

View Figures

View References

1	McKay JA, Williams EA and Mathers JC: Effect of maternal and post-weaning folate supply on gene-specific DNA methylation in the small intestine of weaning and adult apc and wild type mice. Front Genet. 2:232011. View Article : Google Scholar : PubMed/NCBI
2	Ohtaki T, Shintani Y, Honda S, et al: Metastasis suppressor gene Kiss-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
3	Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C and Mundel P: Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene. 22:5298–5305. 2003. View Article : Google Scholar : PubMed/NCBI
4	Wang H, Jones J, Turner T, et al: Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol. 180:1170–1178. 2012. View Article : Google Scholar : PubMed/NCBI
5	Cutait R, Calache JE, Borges JL, et al: The value of colonoscopy in low digestive hemorrhages of unexplained cause: analysis of 132 patients. Rev Paul Med. 96:66–68. 1980.(In Portuguese).
6	Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
7	Lee JH, Miele ME, Hicks DJ, et al: KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 88:1731–1737. 1996. View Article : Google Scholar : PubMed/NCBI
8	Welch DR, Chen P, Miele ME, et al: Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene. 9:255–262. 1994.PubMed/NCBI
9	Lee JH and Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer. 71:1035–1044. 1997. View Article : Google Scholar
10	Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al: Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci. 117:1319–1328. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kotani M, Detheux M, Vandenbogaerde A, et al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 276:34631–34636. 2001. View Article : Google Scholar : PubMed/NCBI
12	Miele ME, Jewett MD, Goldberg SF, et al: A human melanoma metastasis-suppressor locus maps to 6q16.3–q23. Int J Cancer. 86:524–528. 2000.PubMed/NCBI
13	Shirasaki F, Takata M, Hatta N and Takehara K: Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3–q23. Cancer Res. 61:7422–7425. 2001.PubMed/NCBI
14	Goldberg SF, Miele ME, Hatta N, et al: Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 63:432–440. 2003.PubMed/NCBI
15	Lee DK, Nguyen T, O’Neill GP, et al: Discovery of a receptor related to the galanin receptors. FEBS Lett. 446:103–107. 1999. View Article : Google Scholar : PubMed/NCBI
16	Muir AI, Chamberlain L, Elshourbagy NA, et al: AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 276:28969–28975. 2001. View Article : Google Scholar : PubMed/NCBI
17	Hori A, Honda S, Asada M, et al: Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun. 286:958–963. 2001. View Article : Google Scholar : PubMed/NCBI
18	Lee JH and Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 57:2384–2387. 1997.PubMed/NCBI
19	Lee KH and Kim JR: Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer. Oncol Res. 18:107–116. 2009. View Article : Google Scholar : PubMed/NCBI
20	Yan C, Wang H and Boyd DD: KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem. 276:1164–1172. 2001. View Article : Google Scholar
21	Ringel MD, Hardy E, Bernet VJ, et al: Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab. 87:23992002. View Article : Google Scholar : PubMed/NCBI
22	Mitchell DC, Stafford LJ, Li D, Bar-Eli M and Liu M: Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene. 26:1739–1747. 2007. View Article : Google Scholar : PubMed/NCBI
23	Marot D, Bieche I, Aumas C, et al: High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer. 14:691–702. 2007. View Article : Google Scholar : PubMed/NCBI
24	Kostadima L, Pentheroudakis G and Pavlidis N: The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer. Anticancer Res. 27:2499–2504. 2007.PubMed/NCBI
25	Stark AM, Tongers K, Maass N, Mehdorn HM and Held-Feindt J: Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol. 131:191–198. 2005. View Article : Google Scholar : PubMed/NCBI
26	Martin TA, Watkins G and Jiang WG: KiSS-1 expression in human breast cancer. Clin Exp Metastasis. 22:503–511. 2005. View Article : Google Scholar : PubMed/NCBI
27	Dhar DK, Naora H, Kubota H, et al: Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer. 111:868–872. 2004. View Article : Google Scholar
28	Yao HL, Yang ZL, Li YG and Liu GW: In situ hybridization study on the expression of Kiss-1 and KAI-1 metastasis suppressor genes in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 10:274–277. 2007.(In Chinese).
29	Tachibana M, Kinugasa S, Dhar DK, et al: Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus. Arch Surg. 134:50–54. 1999. View Article : Google Scholar : PubMed/NCBI
30	Ikeguchi M, Yamaguchi K and Kaibara N: Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res. 10:1379–1383. 2004. View Article : Google Scholar : PubMed/NCBI
31	Cedrone A, Rapaccini GL, Pompili M, et al: Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver. 16:94–98. 1996. View Article : Google Scholar
32	Hou YK, Wang Y, Cong WM and Wu MC: Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma. Ai Zheng. 26:591–595. 2007.(In Chinese).
33	Ikeguchi M, Hirooka Y and Kaibara N: Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol. 129:531–535. 2003. View Article : Google Scholar
34	Schmid K, Wang X, Haitel A, et al: KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch. 450:143–149. 2007. View Article : Google Scholar : PubMed/NCBI
35	Rigaud G, Moore PS, Zamboni G, et al: Allelotype of pancreatic acinar cell carcinoma. Int J Cancer. 88:772–777. 2000. View Article : Google Scholar : PubMed/NCBI
36	Yatsuoka T, Sunamura M, Furukawa T, et al: Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol. 95:2080–2085. 2000. View Article : Google Scholar : PubMed/NCBI
37	Masui T, Doi R, Mori T, et al: Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun. 315:85–92. 2004. View Article : Google Scholar : PubMed/NCBI
38	Liang S and Yang ZL: Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 32:109–113. 2007.(In Chinese).
39	Singer PA, Cooper DS, Daniels GH, et al: Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med. 156:2165–2172. 1996. View Article : Google Scholar : PubMed/NCBI
40	Stathatos N, Bourdeau I, Espinosa AV, et al: KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab. 90:5432–5440. 2005. View Article : Google Scholar
41	Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin. 53:5–26. 2003. View Article : Google Scholar
42	Jiang Y, Berk M, Singh LS, et al: KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis. 22:369–376. 2005. View Article : Google Scholar : PubMed/NCBI
43	Gao GL, Liu LD, Zou XS and Chen WX: Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour. Zhonghua Fu Chan Ke Za Zhi. 42:34–38. 2007.(In Chinese).
44	Hata K, Dhar DK, Watanabe Y, Nakai H and Hoshiai H: Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer. 43:1452–1459. 2007. View Article : Google Scholar : PubMed/NCBI
45	Cole LA: Phantom hCG and phantom choriocarcinoma. Gynecol Oncol. 71:325–329. 1998. View Article : Google Scholar : PubMed/NCBI
46	Horikoshi Y, Matsumoto H, Takatsu Y, et al: Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 88:914–919. 2003. View Article : Google Scholar : PubMed/NCBI
47	Cole LA and Sutton JM: Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. J Reprod Med. 49:545–553. 2004.PubMed/NCBI
48	Dhillo WS, Savage P, Murphy KG, et al: Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab. 291:E878–E884. 2006. View Article : Google Scholar : PubMed/NCBI
49	Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
50	Nicolle G, Comperat E, Nicolaïew N, Cancel-Tassin G and Cussenot O: Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder. Ann Oncol. 18:605–607. 2007. View Article : Google Scholar : PubMed/NCBI
51	Buchan NC and Goldenberg SL: Intermittent androgen suppression for prostate cancer. Nat Rev Urol. 7:552–560. 2010. View Article : Google Scholar : PubMed/NCBI
52	Ramiah V, George DJ and Armstrong AJ: Clinical endpoints for drug development in prostate cancer. Curr Opin Urol. 18:303–308. 2008. View Article : Google Scholar : PubMed/NCBI
53	Plantade A, Massard C, de Crevoisier R and Fizazi K: Locally advanced prostate cancer: definition, prognosis and treatment. Bull Cancer. 94:F50–F61. 2007.(In French).
54	Creasman WT, Odicino F, Maisonneuve P, et al: Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 95(Suppl 1): S105–S143. 2006.PubMed/NCBI
55	Kang HS, Baba T, Mandai M, et al: GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther. 10:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
56	Nomura H, Sato H, Seiki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55:3263–3266. 1995.PubMed/NCBI
57	Gottsch ML, Clifton DK and Steiner RA: Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive axis. Mol Cell Endocrinol. 254–255:91–96. 2006.PubMed/NCBI
58	Li D, Mitchell D, Luo J, et al: Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes. Endocrinology. 148:4821–4828. 2007. View Article : Google Scholar : PubMed/NCBI
59	Dissanayake SK, Wade M, Johnson CE, et al: The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem. 282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
60	Ohta S, Lai EW, Pang AL, et al: Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer. 114:139–143. 2005. View Article : Google Scholar : PubMed/NCBI
61	Janneau JL, Maldonado-Estrada J, Tachdjian G, et al: Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab. 87:5336–5339. 2002. View Article : Google Scholar : PubMed/NCBI
62	Jiang T, Zhang SL, Lin B, Meng LR and Gao H: Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi. 27:229–231. 2005.(In Chinese).